News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Dunne Michael W.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 1,779 options to buy
@ $0 |
|
| 06/15/2023 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 15,853 options to buy
@ $0 |
|
| 04/03/2023 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 1,299 options to buy
@ $0 |
|
| 01/04/2023 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 761 options to buy
@ $0 |
|
| 12/28/2022 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 3,487 options to buy
@ $0 |
|
| 09/27/2022 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 1,779 options to buy
@ $0 |
|
| 09/09/2022 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Bought 10,000 shares
@ $2.22, valued at
$22.2k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2022 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Exercised 10,494 options to buy
@ $0
Granted 11,426 options to buy
@ $0 |
|
| 07/27/2021 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 80,000 shares
@ $0 |
|
| 06/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/27/2021 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 80,000 shares
@ $0
Sold 33,143 shares
@ $1.73, valued at
$57.3k
|
|
| 10/28/2020 |
4
| Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Bought 61,540 shares
@ $0
Bought 46,155 warrants
@ $0.65, valued at
$30k
|
|
| 02/19/2019 |
4
| Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 85,000 options to buy
@ $5.8, valued at
$493k
|
|
| 09/06/2018 |
4
| Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Bought 500 shares
@ $10, valued at
$5k
|
|
| 08/28/2018 |
4
| Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Bought 500 shares
@ $10, valued at
$5k
Bought 500 shares
@ $10, valued at
$5k
|
|
| 05/30/2018 |
4
| Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Converted 12,730 shares
@ $0
Converted 4,050 shares
@ $0
Converted 2,917 shares
@ $0
Bought 2,000 shares
@ $13, valued at
$26k
Converted 12,730 options to buy
@ $0
Converted 4,050 options to buy
@ $0
Converted 2,917 options to buy
@ $0 |
|
| 05/29/2018 |
4
| Dunne Michael W. (Chief Scientific Officer) has filed a Form 4 on Iterum Therapeutics plc|
Txns:
| Granted 79,567 options to buy
@ $13, valued at
$1M
|
|
| 05/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/13/2016 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Aviragen Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $1.5, valued at
$30k
|
|
| 10/21/2015 |
4
| Dunne Michael W. (Director) has filed a Form 4 on Biota Pharmaceuticals, Inc.|
Txns:
| Granted 35,000 options to buy
@ $1.95, valued at
$68.3k
|
|
| 11/18/2014 |
4
| Dunne Michael W. (Chief Medical Officer) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Disposed/sold 13,220 shares
@ $0
Disposed/sold 281,250 options to buy
@ $0.96, valued at
$270k
Disposed/sold 18,850 options to buy
@ $10, valued at
$188.5k
Disposed/sold 12,500 options to buy
@ $10, valued at
$125k
Disposed/sold 50,000 options to buy
@ $7.49, valued at
$374.5k
Disposed/sold 100,000 options to buy
@ $16.15, valued at
$1.6M
|
|
| 05/22/2014 |
4
| Dunne Michael W. (Chief Medical Officer) has filed a Form 4 on Durata Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $16.15, valued at
$1.6M
|
|
| 02/14/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/26/2012 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|